Jefferies Group LLC Omeros Corp Call Options Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Sep 21, 2023	BUY	$5.67 - $8.54 $1.42 Million - $2.14 Million	250,000 Added 250.0%	350,000 $2.25 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $1.98 Million - $2.99 Million	350,000 New	350,000 $2.25 Million
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $1.34 Million - $1.63 Million	-100,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$14.81 - $19.13 $592,400 - $765,200	40,000 Added 66.67%	100,000 $1.48 Million
Q2 2021 Aug 20, 2021	SELL	$14.81 - $19.13 $147 Million - $189 Million	-9,900,000 Reduced 99.0%	100,000 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $147 Million - $190 Million	9,940,000 Added 16566.67%	10,000,000 $1.48 Million
Q1 2021 Sep 21, 2023	BUY	$14.52 - $23.53 $145,200 - $235,300	10,000 Added 20.0%	60,000 $1.07 Million
Q1 2021 May 14, 2021	BUY	$14.52 - $23.53 $145,200 - $235,300	10,000 Added 20.0%	60,000 $1.07 Million
Q4 2020 Sep 21, 2023	BUY	$10.14 - $15.19 $507,000 - $759,500	50,000 New	50,000 $714,000
Q4 2020 Feb 16, 2021	BUY	$10.14 - $15.19 $507,000 - $759,500	50,000 New	50,000 $714,000

124

25.2M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $541M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.